RegulatoryOfficial

MHRA Strategy 2030 sets mission of health and prosperity through scientific excellence

🇬🇧 MHRA · Mon 16 Nov 2026

The UK regulator's corporate report outlines how it plans to respond to AI, advanced therapies and shifting global supply chains, with new accessible versions added on 16 November.

The Medicines and Healthcare products Regulatory Agency has published MHRA Strategy 2030, a corporate report describing how the agency intends to deliver what it calls health and prosperity for all, through scientific excellence. The document first appeared on 14 October 2026 and was updated on 16 November.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time

Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.

We'll email you a link to confirm your address, then take you to secure checkout (Stripe). Billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. Already a subscriber? Enter your email and the link will sign you in. See our terms and privacy policy.

Official source: MHRA ↗

Article written by VigiEye from the official source (MHRA). AI-assisted; check the source before acting.

More Regulatory All →